Can ketogenic diet offer an effective alternative to antiseizure medication in infants with drug-resistant epilepsy?

The effectiveness of ketogenic diets in lowering seizure frequency among newborns.

Investigational Once-Monthly Injectable Boosts Response Rate in Acromegaly

An investigational treatment for acromegaly — also known as gigantism — was safe and boosted biochemical control, according to final topline findings of the phase

July 24, 2024

Pennsylvania judge sides with drugmakers on first steps for growing GLP-1 lawsuits

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

August 30, 2024

Freeline’s early Gaucher disease data; Shorla raises $35M; Regenxbio to start pivotal DMD trial next year

Freeline’s early data on gene therapy for Gaucher disease: Freeline Therapeutics said Wednesday that its gene therapy for Gaucher disease looked safe so far in

October 5, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.